SF3566

Treatments that may harm fertility informed consent requirement provision
Legislative Session 94 (2025-2026)

AI Generated Summary

Purpose

  • The bill would require health care providers to obtain informed, written consent before performing medical treatments that may harm a patient’s fertility. It aims to ensure patients are informed about potential fertility risks and have access to information and options related to fertility preservation and family building.

Definitions (key terms)

  • Family building: How a person forms a family, including both biological and nonbiological steps.
  • Fertility: The ability to conceive or carry biological children.
  • Fertility specialist: A health care provider with expertise in reproductive health and fertility preservation.
  • Health care provider: A licensed or registered health professional practicing within their licensed scope and state law.
  • Medical treatment: Any prescription drug, procedure, therapy, or intervention that may impact fertility.
  • Patient: The person receiving medical treatment.

Main Provisions

  • Informed consent requirement:

    • A health care provider must discuss with the patient the potential harm a treatment could have on the patient’s fertility.
    • The provider must give the patient an opportunity to consult with a fertility specialist about the treatment’s impact, fertility preservation options, and family building options.
    • The patient must give prior written informed consent, affirming they were informed about the fertility risks, understood them, and authorize the treatment.
  • Prohibited conduct:

    • Providers must not influence a patient’s decision by discouraging the patient from consulting a fertility specialist or exploring fertility preservation or family-building options.
  • Disciplinary action:

    • A health care provider who violates the requirements could face disciplinary action from the relevant licensing board.
    • A patient harmed by the violation may file a complaint with the appropriate licensing board.
  • Oversight and monitoring:

    • The commissioner of health must establish procedures to monitor compliance with these requirements.

Significance and Potential Impact

  • Establishes a formal, patient-centered process to consider fertility impacts before treatment.
  • Requires proactive discussion and access to fertility-related information and services.
  • Introduces accountability through licensing boards and state health oversight.
  • May influence how health care providers counsel patients and obtain consent for treatments with fertility implications.

How this changes existing law

  • Creates a new state requirement for informed consent specifically tied to treatments that may affect fertility.
  • Adds defined terms related to fertility, preservation, and family building to guide practice.
  • Shifts some responsibility for oversight and enforcement to licensing boards and the commissioner of health.

Relevant Terms - informed consent - fertility - fertility preservation - family building - fertility specialist - health care provider - medical treatment - patient - health-related licensing board - commissioner of health - disciplinary action - consult with a fertility specialist - monitoring compliance

Bill text versions

Showing the most recent version. There are  1  total versions. You must be logged in  to view additional bill text versions.

Past committee meetings

You must be logged in  to view 1  past legislative committee meetings.

Actions

DateChamberWhereTypeNameCommittee Name
February 17, 2026SenateActionIntroduction and first reading
February 17, 2026SenateActionReferred toHealth and Human Services
Showing the 5  most recent stages. This bill has 2  stages in total. Log in to view all stages

Citations

You must be logged in  to view citations.

Progress through the legislative process

17%
In Committee

Sponsors

You must be logged in  to view sponsors.

Loading…